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ABSTRACT

RESTRUCTURING OF THE AXON INITIAL SEGMENT IN MOUSE MODELS OF
NEURODEVELOPMENTAL DISORDERS

By
Rachel Ali Rodriguez
Dr. Rochelle Hines, Examination Committee Chair
Assistant Professor of Psychology
University of Nevada, Las Vegas
Neurodevelopmental disorders (NDDs) affect more than 36% of children in
countries with low- and middle- incomes (Boivin, 2015; McCoy, 2016). Interestingly, these
heterogeneous disorders share a high incidence of epileptic seizures, suggesting a
shared pathology. Seizures result when neuronal firing activity becomes disturbed and
neurons fire excessively or in unregulated patterns. A key site in the control of neuronal
firing patterns is the axon initial segment (AIS), where the local density of proteins and
the morphology of the AIS in part determine the firing of neurons. We hypothesized that
a disruption in the morphology and/or composition of the AIS can lead to the phenotypes
seen in neurodevelopmental disorders, including seizures. To study this possibility, we
performed morphological analyses of the AIS of cortical pyramidal neurons in mouse
models of NDDs with a high incidence of epilepsy (Gabra2-1 and Mecp2+/-). Our results
reveal morphological changes at the AIS of both, Gabra2-1 and Mecp2+/- mice, when
iii

compared to wild-type mice. Understanding neuropathological changes leading to these
heterogeneous disorders will increase knowledge of the general underlying mechanisms
thus contributing to the development of better therapies.
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CHAPTER 1: AN INTRODUCTION TO THE PROPOSED STUDY

Neurodevelopmental disorders (NDDs) are characterized by deficiencies in language
development, social interaction, and cognition, and include stereotyped behavior. These
disorders are often associated with a high incidence of epilepsy (American Psychiatric
Association, 2013; Rubenstein & Merzenich, 2003), a brain dysfunction characterized by
recurrent spontaneous seizures. Of particular interest, the comorbidity between NDDs
and epilepsy provides insight suggesting that the neuropathology underlying these
disorders may relate to impaired control of neuronal signaling patterns. Past research on
NDDs has focused on excitatory signaling, but recent studies have also noted
abnormalities in inhibitory signaling (Ali Rodriguez et al. 2018), although investigations
into specific subtypes of inhibitory synapses have not been conducted. Inhibitory
synapses are diverse in the subcellular domain of the postsynaptic cell that they target,
and the composition of the postsynaptic receptor cell can dramatically affect function.
Therefore, unraveling epilepsy’s inter-relationship with NDDs through detailed analysis of
inhibitory synapse subtypes may provide further knowledge of shared neuronal response
that can account for both the NDDs and the epilepsies.
Neuronal signaling controls not only our responses to internal and external body
environments, but also maintains an internal oscillatory pattern within the brain (Ali
Rodriguez et al., 2018). In typical development of the central nervous system, neurons
are firing continuously in controlled patterns. During a seizure, the brain’s internal
oscillation is disrupted and neurons fire excessively or in unregulated patterns often
producing uncontrolled muscle movements and/or impacting consciousness (Ali
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Rodriguez et al., 2018). Neuronal firing patterns are controlled by the axon initial segment
(AIS), which is the site of action potential (AP) generation in most neuronal cell types
(Clark B.D. et al., 2009, 2015; Kole, M.H., et al. 2008). The AIS’s composition and
morphology in part determine neuronal firing. These parameters undergo important
modifications during development and can be modified in reaction to a change in neuronal
excitability (Grubb and Burrone, 2010; Kuba et al., 2010). It remains to be determined
how the morphology and composition of the AIS is affected in NDDs and if this ultimately
contributes to phenotypes such as seizures.
This study focuses on analyzing the morphology and composition of the AIS of
cortical pyramidal cells in layer 3 of the medial prefrontal cortex (mPFC) in mouse models
of NDDs with epilepsy as a prevalent feature. This work will advance our knowledge of
the physiological and pathological conditions under which modifications to the AIS occur,
as well as the molecular mechanisms underlying these modifications. A greater
understanding of the direct role of AIS morphology and composition in typical
neurodevelopment and NDDs may open new avenues for targeted therapies to treat
NDDs and epilepsy.
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CHAPTER 2: LITERATURE REVIEW

Neurodevelopmental Disorders
General Features and Heterogeneity
The term NDD describes a heterogeneous group of conditions typically manifesting early
in development. Examples of NDDs include intellectual disability, Autism Spectrum
Disorders (ASD), Rett syndrome (RS), Angelman syndrome (AS), and Dravet syndrome
(DS). The multiple genetic contributors that cause NDDs result in similar symptoms which
can include difficulties with language and speech, motor skills, behavior, memory,
learning, and/or other neurological functions (American Psychiatric Association, 2013).
Interestingly, besides the core features, individuals with NDDs are also commonly
diagnosed with epilepsy (American Psychiatric Association, 2013; Rubenstein &
Merzenich, 2003). The shared symptomatology among NDDs suggests that a common
pathogenic process may underlie these disorders (Ali Rodriguez et al., 2018).
Most NDDs are associated with an extremely heterogeneous and inconsistent
genetic profile (i.e. multiple gene disorders) making them difficult to study (Hu et al.,
2009). In particular, ASD is a prototypical NDD which functions as a reference point to
the other disorders in this category (Ali Rodriguez et al., 2018). ASD and other disorders
possessing “autistic-like features” are associated with impaired sensory processing,
disrupted brain activity patterns from electroencephalogram (EEG) recordings, and
epilepsy, with widely varying degrees of severity (Rubenstein & Merzenich, 2003; for
review see Ali Rodriguez et al., 2018). NDDs also commonly co-occur with specific and
global developmental and learning disabilities (Thapar et al., 2011). For example,
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individuals with ASD may also be diagnosed with ADHD (Thapar et al., 2011). To date,
more than 100 genes and 44 genomic loci have been reported in individuals with ASD or
autistic-like behaviors (Betancur, 2011).
Some NDDs are monogenetic in nature (i.e. single gene disorders). Knowing the
genetic cause allows us to use monogenetic disorders as prototype for the genetic,
molecular, and neurobiological analysis of NDDs, in general, to better understand and
hopefully treat these disorders. Examples of monogenetic NDDs include RS, AS, and DS.
Monogenetic Neurodevelopmental Disorders
Rett Syndrome
RS is characterized by a postnatal disruption of the nervous system caused by a mutation
in the MECP2 gene encoding methyl-CpG-binding protein 2 (MeCP2) (Kozinetz et al.,
1993; for review see Ali Rodriguez et al., 2018). The precise function of MeCP2 has been
difficult to pin down even though it has been researched for several decades. We currently
know that an important function of MeCP2 is to bind methylated DNA and regulate long
gene expression by modifying chromatin structure (Meehan et al., 1992; Nan et al., 1997;
for review see Ali Rodriguez et al., 2018). Due to this function, mutation of this gene can
lead to overexpression of other gene products and thus have a significant impact on the
function of the brain (Gabel et al., 2015).
An important feature of RS is that MECP2 is an X-chromosome linked gene (Amir
et al., 1999). Since males have only one X-chromosome, mutations result in more severe
symptoms, with most RS males dying soon after birth (Meloni et al., 2000; for review see
Ali Rodriguez et al., 2018). The few males that survive have more mild mutations, exhibit
4

varying degrees of intellectual disability, and are often diagnosed with other disorders
such as attention deficit/hyperactivity disorder (ADHD) (Adegbola et al., 2009; Shibayama
et al., 2004; for review see Lombardi et al., 2015). RS is not as lethal in females because
they have two X-chromosomes, but it represents one of the leading genetic causes of
intellectual disability and developmental regression (Neul & Zoghbi, 2004; for review see
Ali Rodriguez et al., 2018). Studies performed on females showed that the severity of RS
symptoms vary broadly depending on the inactivation pattern of the x-chromosome
(Dragich et al., 2000) but symptoms usually include severe impairments that drastically
affect a child’s life. Many children become wheelchair bound and those who walk display
an abnormal, stiff-legged gait (Chahrour & Zoghbi, 2007). Characteristics Features of
other NDDs such as stereotyped behaviors, loss of language skills, learning and memory
deficits, and loss of social skills are also seen in RS (Chahrour & Zoghbi, 2007). RS’s
core symptoms are often accompanied by apraxia, ataxia, impaired coordination,
Parkinson-like tremors, respiratory dysrhythmias, sometimes premature lethality, and
seizures (Chahrour & Zoghbi, 2007; Chao et al., 2007). Cortical hyperexcitability primarily
in the frontal-central regions has been seen on the EEG of RS patients (Weng et al.,
2011). Particularly interesting, approximately 60% to 80% of females with RS develop
epilepsy (Vignoli et al., 2017), and the prevalence of epilepsy has been correlated with
the severity of the syndrome (Tarquinio et al., 2017). Longitudinal studies estimate a 90%
incidence of epilepsy in RS patients during their lifetime (Tarquinio et al., 2017).
We focus our research on RS due to its monogenetic nature, high epileptic profile,
and shared symptomatology with other NDDs. Knowledge of the specific genetic
mutations that cause RS makes it easier to study thus, we use this disorder as a prototype
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for our analysis of NDDs. The high incidence of epilepsy and/or seizures seen in patients
with RS (Dolce et al., 2013; Tarquinio et al., 2017; Vignoli et al., 2017) allows us to use
this symptom to study a commonality among NDDs. Interestingly, besides RS’s shared
epileptic symptomatology with other NDDs, mutations in MECP2 have also been seen in
some cases of non-syndromic autism, Angelman-like syndrome, childhood-onset
schizophrenia, and learning disabilities (Carney et al. 2003; Harvey et al. 2007; Suter et
al. 2013; Watson et al. 2001).
Other Monogenetic Neurodevelopmental Disorders Associated with
Epilepsy
AS and DS are other examples of monogenetic NDDs associated with epilepsy. AS is
caused by loss of activity within the UBE3A gene on chromosome 15 (Ali Rodriguez et
al., 2018). This syndrome is characterized by severe intellectual disability, frequent
laughter/smiling, ataxic movements, speech impairment, and interestingly, a high
incidence of epilepsy (Buiting et al., 2016, for review see Ali Rodriguez et al., 2018). In
the case of AS, epilepsy occurs in about 80% of the patients (Thibert et al., 2009; 2013).
On the other hand, DS is an early childhood-onset form of developmental epilepsy with
frequent and/or prolonged seizures (Han et al., 2012, for review see Ali Rodriguez et al.,
2018). Developmental epilepsy also falls under the category of NDDs due to the
developmental factors known to contribute to the onset of epilepsies (Bozzi et al., 2012,
for review see Ali Rodriguez et al., 2018). This syndrome is mainly caused by de novo
mutations in the SCN1A gene (Scheffer et al., 2009). Early onset is characterized by both
febrile and non-febrile seizures, but it later advances to myoclonic and/or partial seizures,
ataxia, and psychomotor delay (Selmer et al., 2009; for review see Ali Rodriguez et al.,
6

2018). Interestingly, NDD features are also frequently observed in patients with
developmental epilepsy the same way as epilepsy has a high incidence in patients with
NDDs. DS, for example, is also characterized by cognitive impairment, hyperactivity
and/or impulsiveness, motor deficits, and autistic-like behavior [Han et al., 2012, Scheffer
et al., 2009).
NDDs have been the subject of extensive research, but mechanisms underlying
the shared symptomatology among NDD subtypes have yet to be studied. The associated
symptoms among NDDs may be indicative of impaired neuronal signaling in the brain
caused by different underlying neuropathologies. Therefore, analyzing neuronal changes
that may result in brain signaling disruptions may provide an advance in our
understanding of the neuropathology of NDD subtypes.
Common Neuropathology in Neurodevelopmental Disorders- Epilepsy
As we have mentioned in the sections above, epilepsy is a frequent feature of NDDs.
Particularly, epilepsy is prevalent in ASD, AS, and RS and is characteristic of DS (Ali
Rodriguez et al., 2018). Epilepsy is more frequent in children with intellectual disability
(Goulden et al., 1991; McGrother, 2006; Myers & Mefford, 2015). Also, childhood onset
epilepsy, temporal or frontal lobe onset of seizures, and intractable epilepsy are
associated with neurobehavioral, psychiatric, and cognitive disabilities (Berg, 2011;
Hamiwka & Wirrell, 2009). The fact that heterogeneous NDDs share a common
neuropathological symptom suggests that a one-size-fits-all therapeutic approach could
be effective for these disorders.

7

A person diagnosed with epilepsy would have a tendency for recurrent
spontaneous seizures. During a seizure, neurons "fire" uncontrollably affecting the way
the person behaves, moves, thinks, or feels temporarily. By zooming in on neurons and
comparing how these cells are affected by NDDs, we may be able to identify common
affected pathways.
Neurons and their Signals
Neurons, the fundamental signaling units of the brain, are highly specialized cells with a
complex functional and morphological organization. Ever since Ramon y Cajal described
the neuronal polarization in 1891, we know that all neurons can receive, integrate, and
transmit signals to other cells (Shepherd, 1991). These functions are accomplished by
the neuron’s four distinct domains; dendrites, soma, axon, and axon terminals. Neurons
receive chemical signals through neurotransmitter receptors located mostly at the soma
and dendrites. The signals are then propagated in the form of postsynaptic potentials
(PSP) until they reach the axon. The axon is a neuronal domain of special interest to us
because this is where electrical signals, in the form of action potentials (AP), are
transmitted to other neuronal cells.

In particular, we are interested in the AIS

compartment of the axon because this is where APs are initiated (Clark et al., 2009, 2015;
Kole et al. 2008). The signal that is initiated by the AIS and propagated through the axon
is then sent to other cells as chemical signals (neurotransmitters) by the axon terminal.
Electrical signaling
A neuron at rest has a negative charge on the inside relative to the positive charge on the
outside of its membrane (resting potential). This change in voltage is due to the
accumulation of large negatively charged protein molecules in the cell cytoplasm, which
8

electrostatically attract potassium (K+) ions inside the cell through open channels. The
change in voltage is also due to the accumulation of sodium (Na+) ions outside the cell
through the sodium-potassium pump. When sodium voltage (Nav) channels are activated
by neurotransmitters released from another neuron, positively charged Na+ ions enter
the cell causing a rapid change of electrical charge across the membrane. If the change
from the transient inward current is a strong enough stimulus, it triggers an excitatory
postsynaptic potential (EPSP) that may summate to generate an AP, a rapid change in
electrical potential of the cell’s surface. During the AP, more Na+ ions enter the cell
allowing a directional positive flow along the negatively charged axon. Sodium channels
then close and Voltage-gated K+ channels (KV channels) open; more K+ ions exit than
enter the cell eventually making that membrane section more negative than its resting
potential. Finally, KV channels close and the membrane returns to its resting potential. In
this way, the electrical signal travels down the axon until it reaches the axon terminal
where neurotransmitters are released onto another neuron, passing on the signal.
(Kandel & Mack, 2014)
Axon Initial Segment
The generation and transmission of electrical signals in the form of APs occur at the AIS,
a subcellular compartment of neuronal cells measuring approximately 20-25µm in length
(Clark et al., 2009, 2015; Kole et al. 2008). Due to its important function in allowing for
neuronal communication in the brain, the AIS is strategically located at the most proximal
part of the axon (Clark et al., 2009, 2015; Kole et al. 2008). It differentiates
morphologically and functionally from the dendrites, soma, and the rest of the axon which
implies that the morphology, protein composition, and localization of the AIS are important
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to its functions in neuronal excitability (Clark et al., 2009, 2015; Kole et al. 2008).
Therefore, it is an intriguing possibility that any disruption of the AIS, such as a change in
its length, location, and ion channel expression may be a key player in certain phenotypes
common to NDDs. Recent studies have demonstrated that the AIS undergoes important
modifications during development and that plasticity modulated by presynaptic activity
also occurs in the matured neuron leading to alterations in neuronal excitability (Grubb &
Burrone, 2010). However, the molecular mechanisms that affect the development,
composition/morphology, and subsequent plasticity of the AIS remain obscure.
Composition
The AIS has three main cross-sectional layers or regions: the plasma membrane
(outermost surface), submembrane cytoskeleton corresponding to the plasma membrane
undercoat (middle layer), and inner AIS shaft (cytoplasmic region) (Jones & Svitkina,
2016). The plasma membrane of the AIS is characterized by a high density of proteins
including voltage-gated ion channels important for the AIS’s electrical properties (Clark et
al., 2009, 2015; Kole et al. 2008; Rasband, 2010). These voltage-gated ion channels are
supported by specific scaffold proteins enriched at the AIS submembrane cytoskeleton
(Rasband, 2010). The central component of this layer is ankyrin-G (Ank-G) (Kordeli et al.,
1995) which organizes its scaffold by anchoring AIS-specific proteins to the membrane
(Hedstrom et al., 2008). The cytoplasmic region is composed of neurofilaments,
microtubules, and actin filaments which form actin rings that periodically organize the AIS
protein channels (Xu et al., 2013). A disruption to this AIS internal organization could
affect action potential generation, although there is still no research backing this idea.
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The concentration of various channel proteins at the AIS depend on ankyrin-G
(Ank-G) (Boiko, 2007; Jenkins, 2001; Leterrier, 2016). For example, Ank-G anchors Nav
channels to the membrane of the AIS by binding to a cytoplasmic II–III loop (Garrido,
2003, 2006). Interestingly, this II–III loop in also contain a membrane sequence that
removes these channels from non-AIS neuronal compartments (Fache et al., 2004, 2008)
making NaV enriched at the AIS. Various experiments have shown that mice with
decreased Ank-G expression in the cerebellum exhibit loss of ability of GABAergic
neurons to fire APs mainly due to the inability of proteins like Nav channels to anchor to
their neuronal membrane (Jenkins & Bennett, 2001; Zhou et al., 1998). Ank-G also
interacts with the cell adhesion molecules NrCAM and Neurofascin-186 and KV channels
(Kole et al. 2008; Leterrier et al., 2015; Xu et al., 2013). The interaction of Ank-G with AIS
membrane proteins is important for its formation and maintenance, however, how and
where they interact is still inconclusive.
A key player at the AIS is the Nav channel protein which is crucial to its function.
This ion channel is highly enriched at the AIS and give it its unique electrical properties
useful for AP generation and transmission (Kole, M.H., et al. 2008). The main Nav
channels at the AIS are Nav1.2 and Nav1.6 which localize, respectively, to the proximal
and distal AIS (Hu et al., 2009). An elegant study, using a Nav channel-binding neurotoxin,
showed a non-uniform distribution of NaV channels in neurons with the highest density of
Nav channels localizing to the AIS (Catterall, 1981). Today we know that this high density
is approximately 50 times greater at the AIS than at the soma (Kole et al., 2008) which
allows for the regulation of neuronal AP firing, thus regulating communication in the brain.
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Also highly enriched at the AIS and important for the generation and propagation
of APs are the KV channels (Boiko, 2007; Jenkins, 2001; Kole et al., 2008; Leterrier et al.,
2015; Xu et al., 2013). In particular, KV channels regulate membrane potential at rest, are
important for AP repolarization, neuronal excitability suppression, and different AP
properties including amplitude and firing frequency and duration (Brown & Adams, 1980;
Debanne et al., 2011; Kole et al., 2008; Rasband, 2010). There are many KV channels
that localize to the AIS and their specific combinations characterize different neuronal cell
types (Vacher et al., 2008). The most common AIS KV channels are the KV1, KV2, and
KV7 subfamilies (Clark et al., 2009).
The AIS plays an important role in neuronal signaling which may be modulated
through changes in its morphology and protein composition. For example, the amount of
NaV and KV channels localized to the AIS and the presence of Ank-G to cluster these
channels may influence neuronal excitability. Recent research shows that the AIS adjusts
its morphology, composition, and position in response to changes in input to balance
neuronal excitability (Grubb & Burrone, 2010; Kuba et al., 2010). These features have
been shown to adapt to developmental and physiological conditions (Grubb & Burrone,
2010; Kuba et al., 2010). Given the importance of the AIS’s function in the generation of
APs and its ability to adapt to changes, we can see how pathological disruptions of its
morphology and/or composition could profoundly affect neuronal communication in our
brain. In fact, the AIS has recently been the target of several research studies in
neurodevelopmental and psychiatric disorders, neurodegenerative diseases, and brain
trauma (Debanne & Garrido, 2018; Del Puerto et al., 2015).
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Development and Plasticity
Neuronal development is critical to ongoing functioning thus, understanding the
development of each of its components is important for the generation of targeted
therapies. However, despite the years of research, the exact time of events and
mechanisms for the formation of the AIS and subsequent changes is still poorly
understood. We know that AIS formation begins to form early in development during the
time of axon/dendrite specification and before the formation of most synaptic connections
(Barnes et al., 2009). We also know that the AIS differentiates from other neuronal
compartments in the distribution of specific proteins and that this contributes to its
function. Ankyrin G and NaV channels are seen first at the AIS (Jenkins & Bennett, 2001),
while KV channels appear latter in its development (Sanchez-Ponce et al., 2012).
However, we still do not fully understand most of the mechanisms that drive these proteins
to the AIS nor the mechanisms behind AIS plasticity after its development.
Insight into the refinement of neuronal communication has been seen through
multiple forms of plasticity described by researchers throughout the years. For example,
the AIS has been shown to adapt to physiological or pathological cellular changes thus
causing modifications in neuronal excitability (Grubb & Burrone, 2010; Kuba et al., 2010).
Some examples of these AIS refinements include changes in length, location, and protein
expression.
Changes in the length and/or location of the AIS have been observed in multiple
studies possibly to fine-tune AP generation (Kuba & Ohmori, 2009; Kuba, 2010; Grubb &
Burrone, 2010; Kaphzan et al., 2011). An elegant study on avian nucleus magnocellularis
neurons, by Kuba and Ohmori, demonstrated an increase in length and sodium channel
13

clustering of the AIS after unilateral cochlear ablation. This increase in AIS length
occurred within days with a maximum of 1.7-fold by the 7th day. As a result, neurons had
increased whole-cell Nav currents, faster spikes, and lower spike thresholds (2009).
Grubb and Burrone demonstrated a different form of AIS plasticity. Interestingly, in
cultured hippocampal neurons, the AIS compartment moved away from the soma by up
to 17μm after membrane potential was raised by altering extracellular K+ ions or by
evoking APs in bursts via expression of the light-activated cation channel,
channelrhodopsin-2. This relocation of the AIS involved movement of all investigated
components including channels and associated scaffolding proteins, occurred within
days, was reversible, and resulted in a decrease in neuronal excitability (2010). In a
couple of studies, the length and the location of the AIS was also shown to vary with the
tuning frequency of neurons. With higher tuning frequency, AIS are shorter in
magnocellulary neurons, and are shorter and more distally localized in nucleus laminaris
neurons (Kuba et al., 2006; Kuba & Ohmori, 2009). Kuba also saw an elongation of the
AIS in an avian brainstem auditory neuron after deprivation of sensory inputs which
caused spontaneous firing in some neurons (2010). These changes at the AIS suggest a
compensatory attempt to restore neuronal activity.
Changes in the AIS were also seen in a mouse model of AS, a NDD often
associated with severe epilepsy and intellectual/developmental disability. This study
found alterations in excitability during the resting state and the firing state, and intrinsic
AIS membrane properties in hippocampal pyramidal neurons of a mouse model of AS
when compared to the wild-type littermates (Kaphzan et al., 2011). Such altered AIS
properties included an increase in its length and in the expression of Nav1.6 channels
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and ankyrin-G (Jiang et al., 1998; Kaphzan et al., 2011). Interestingly, the mouse model
of AS used in this study did not develop epilepsy (Jiang et al., 1998; Kaphzan et al., 2011).
The studies mentioned above have demonstrated that neuronal excitability can be
modulated through changes at the AIS. Thus, morphological and/or compositional
changes at the AIS may contribute to the pathophysiology of NDDs in which neuronal
excitability is affected. Furthermore, because AIS dysfunction is implicated in a variety of
neuronal excitability disorders (Wimmer et al. 2010) a lack-of AIS plasticity may also be
a dysfunction. It remains to be established whether changes at the morphology and/or
composition of the AIS result as a consequence of or plays a causal role in disease
pathogenesis. More research needs to be done on this previously unappreciated possible
contributor of NDDs and epileptic pathology.
Chemical Signaling
Neurons transmit signals to other neurons through chemicals called neurotransmitters
which can either be excitatory or inhibitory. Pyramidal neurons send excitatory signals by
releasing neurotransmitters such as glutamate; these signals make postsynaptic neurons
more likely to generate an AP. When excitatory neurotransmitters are released by the
axon terminals, they bind to receptors at the postsynaptic membrane thus, activating the
ion channels. On the other hand, inhibitory signals from neurotransmitters released
mostly by interneurons, such as GABA, make postsynaptic neurons less likely to generate
an AP. During an inhibitory signal, the inhibitory neurotransmitters bind to postsynaptic
membrane receptors that gate a channel permeable to chloride and bicarbonate ions.
These ion flow into the postsynaptic cell causing its membrane to become more negative.
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Relying on the integration of excitatory and inhibitory signals, each neuron then makes
the yes-or-no decision to generate their own AP.
Excitatory and inhibitory signals typically work in together to achieve a regulated
signaling pattern or oscillation resulting in healthy cognition and behavior. This principle
originated from Rubenstein and Merzenich’s theory which implies that NDDs result from
an atypical “balance” between excitation and inhibition (2003; for review see Ali Rodriguez
et al., 2018). Excitatory synapses are often located farther from the AIS, mainly in the
soma and dendritic domains (Peters, 2002). Inhibitory synapses are formed by
interneurons, including basket cells that often target the soma and chandelier cells which
mostly synapse at or near the AIS (Freund & Katona, 2007; Gao & Heldt, 2016; Nusser
et al., 1996; for review see Ali Rodriguez et al., 2018). Having inhibitory synapses closer
to the AIS results in greater control and modulation of excitation, so that AP generation
can be patterned and regulated.
An atypical pattern or oscillation between excitatory and inhibitory signals is
directly related to the AIS because this is where APs are generated (Ali Rodriguez et al.,
2018). Morphological and/or compositional changes at the AIS may contribute to the
pathophysiology of NDDs. Furthering research is fundamental to gaining insight into how
changes at the AIS impact typical and atypical neurodevelopment.
GABAA Receptors and GABA
A key-player protein in neuronal inhibitory signaling is the gamma-aminobutyric acid type
A receptor (GABAAR). This protein is an ionotropic receptor and ligand-gated ion channel
that is also enriched at the AIS. It binds to γ-aminobutyric acid (GABA), the major
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inhibitory neurotransmitter in the matured central nervous system. As briefly mentioned
above, when GABA binds to the GABAAR, the receptor selectively conducts Cl- through
its pore, making the neuron less likely to fire an AP (hyperpolarization).
Composition
GABAARs have a pentamer subunit combination which can be made up from α(1-6), β(13), γ(1-3), δ, ε, θ, π, and ρ(1-3) (Rudolph & Möhler, 2006). The most abundant subtypes
of GABAARs are composed of α1-3, β1-3 and γ2 subunits (Jacob et al., 2008; Lüscher &
Keller, 2004; Rudolph & Möhler, 2006; for review see Ali Rodriguez et at., 2018), each
GABAAR subtype having unique localizations and functions. GABAARs containing the
subtypes α1 & α2 are localized to specific types of synapses and have distinct functions
such as different decay times. GABAARs containing α1 subunits are enriched at inhibitory
synapses on the dendrites, while α2 subunits are localized at inhibitory synapses forming
on the AIS (Freund & Katona, 2007; Gao et al., 2016; Hines et al., 2018, Nusser et al.,
1996). GABAA α2 receptors localized at the AIS may influence the output of cortical
pyramidal neurons. Most of these GABA-ergic synaptic inputs are received from a specific
set of axo-axonic interneurons called chandelier cells (ChC) (Somogyi et al., 1998). Inan
and colleagues conducted a study which concluded that a single ChC has approximately
a hundred presynaptic boutons, which innervate 35–50% of pyramidal neurons (2013).
Thus, the localization of these inhibitory synapses at the AIS are of special interest
because of the AIS’s function of generating APs in the majority of neurons (Howard et al.,
2005; Nusser et al., 1996; Zhu et al., 2004).
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Development and Plasticity
Rett Syndrome
A dysfunction of GABAergic inhibitory signaling has been highlighted in studies on Mecp2
knockout mice models, besides the association of RS with epilepsy. In particular, a
dysfunction of specific GABAAR subunit expression and function. Recent findings, by
Medrihan L. et al., demonstrated that a deletion of Mecp2 in mice only from the
GABAergic inhibitory neurons is able to replicate some aspects of the human disease.
This study indicated decreased levels of the GABAARs subunits α2 (typically synaptic)
and α4 (typically extrasynaptic) paralleled by reduced levels of GABA released and
vesicular inhibitory transmitter transporter in the ventrolateral medulla (2008). Chao and
colleagues later demonstrated that subtle perturbation of GABAergic neuronal function
such as a loss of MeCP2 from GABAergic neurons contributes to neuropsychiatric
phenotypes. These Mecp2 deficient mice from GABA-releasing neurons recapitulated
several features of RS and other NDDs. Normal behavior is initially seen in these mice,
but they later develop forepaw stereotyped movements, compulsive grooming, increased
sociability, impaired motor coordination, learning/memory deficits, abnormal EEG
hyperexcitability, severe respiratory dysrhythmias, and premature lethality (2010).
Another recent study, by Zoghbi et al., restored neuronal inhibitory function by genetically
re-expressing Mecp2 in GABAergic neurons of Mecp2 KO mice. The rescue mice had
restored GABA concentrations to wild-type levels, no visible behavioral seizures, and
normalized activity patterns in EEG recordings in five out of six mice (2016).
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Other Neurodevelopmental Disorders and Epilepsy
GABAAR and cortex neurotransmission dysfunction on GABA have been implicated with
NDDs associated with a high incidence of epilepsy (Pelc et al., 2008; for review see Ali
Rodriguez et al., 2018). GABAAR genes are present in chromosome 15; specifically, the
GABRB3, GABRA5, and GABRG3 genes encoding β3, α5, and γ3 subunits, respectively.
As mentioned earlier, AS is caused by loss of activity within the UBE3A gene on
chromosome 15 (Ali Rodriguez et al., 2018). The clustering of this GABAAR subunit gene
in chromosome 15 insights that GABA neurotransmission may also be involved in AS
(Pelc et al., 2008) and possibly other NDDs. Interestingly, the GABRB3 gene has been
associated with epilepsy in humans (Pelc et al., 2008). In addition, a study performed in
monkeys with partial epilepsy showed a loss of GABA-ergic synapses at the AIS of
cortical pyramidal neurons (Ribak, 1985). Neuronal hyperexcitability and epilepsy have
also been shown in mutations that cause a decrease in GABAAR (Tan et al. 2007). These
studies involving mutations of the GABAARs may indicate a connection between epilepsy
and AIS function.
Some research performed on the channels and receptors enriched at the AIS have
led to current anti-epileptic treatments. Anti-epileptic drugs (AEDs) are numerous, with
multiple different mechanisms of action. For example, some AEDs act on the NaV
channels by either blocking their repetitive activation (phenytoin, carbamazepine) or by
enhancing their slow inactivation (lacosamide). Another example of a mechanism through
which AEDs act is by enhancing the GABAARs (phenobarbital, benzodiazepines).
Although treatments exist, it is important to consider that about 1 out of 3 people with
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epilepsy live with uncontrollable seizures because available treatments are ineffective
(Epilepsy Foundation, 2014).
Modeling Neurodevelopmental Disorders
Gabra2-1 Mouse Model for Developmental Epilepsy
Our lab became interested in the relationship between the inhibitory synapses at the AIS
and neurodevelopmental epilepsy. In particular, we wanted to understand the factors
involved in the selective localization of the GABAAR containing the α2 subunits at the AIS.
Remember, having inhibitory synapses on the AIS results in greater control and
modulation of AP generation. Previous knowledge had suggested that gephyrin was an
interacting partner to both types of subunits (α1 and α2), but other factors must be
involved for selective subunit localization to occur. Research at our lab suggested that
the α2 subunit preferentially binds to collybistin and this interaction seems to be what
allows its localization at the AIS (Hines et al., 2018). The GABAAR α subunit has a large
intracellular loop between transmembrane domains 3 and 4 which mediates interaction
with gephyrin in ɑ1 and α2, and interaction with collybistin in ɑ2 only. From this
knowledge, we hypothesized that mutating the intracellular loop of the ɑ2 subunit would
decrease its localization at the AIS; this in turn would profoundly affect neuronal
excitability.
To test this hypothesis, our lab used the deference in preferential binding of α1
and α2 subunits of the GAABAAR to generate the Gabra2-1 knock-in mouse. Specifically,
we substituted a portion of the amino acids 358-375 at the α2 loop with that of α1. This
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loop switch prevents collybistin to bind to the mutated GABAAR α2 which in turn prevents
GABAAR α2 to localize at the AIS.
The following is a summary of the most important findings made by our lab pertaining the
Gabra2-1 mouse model:
According to previous studies by our lab, Gabra2-1 mouse mutation causes a loss
of α2 subunits located to the AIS and thus a loss of inhibitory presynaptic terminals is
seen via staining for the vesicular GABA transporter (VGAT). Gabra2–1 mice have an
increased susceptibility to seizures and early mortality, and increased anxiety in
surviving mice. A proportion of Gabra2-1 pups also die in the late postnatal period
(PND10-25), in particular, the homozygotes for the disorder. Early mice death is likely
related to seizures observed during this time. (Hines et al., 2018) This mutation allows us
to examine the impact of AIS modulations caused by malfunctioning GABA signaling in
order to advance our understanding of the functional role of this important cellular domain.
Mecp2+/- Mouse Model for Rett Syndrome
RS is a monogenetic disorder; knowing its genetic cause makes it a good model to begin
our research on NDDs, unlike other NDDs which are heterogeneous in nature. Also, the
major human phenotypes of RS have been readily recapitulated in mice (Lombardi et al.,
2015) allowing us to use this model system to understand the underlying pathology and
neuronal dysfunction in RS and to get insights into the pathophysiology of NDDs more
generally. Researchers have developed multiple mice models of RS involving Mecp2
gene deficiency to study the underlying neuropathology. The Heterozygous female
Mecp2tm1.1Bird mice (Mecp2+/-) mouse model was created by Adrian Bird’s group at the
University of Edinburgh and is one of the first mice models generated. It lacks exons 3
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and 4 thus, blocking MeCP2 expression in the entire organism (Guy et al., 2001). These
female mice are initially normal but slowly develop a stiff, uncoordinated gait, breathing
difficulties, and hindlimb clasping (Guy et al., 2001). Chen and colleagues (2001) also
noticed that neuron specific deletion of Mecp2 is enough to produce symptoms similar to
those that manifest in RS. Also, a mouse model with truncation mutations, Mecp2308,
portray the progression of symptoms through development seen in RS patients (Chen et
al., 2001). Other mutant mice models have also been reported to resemble RS symptoms,
but there is currently more information for the Mecp2 +/- mouse model in the literature.
Most importantly, out of all available mice models, most features from the human disease
are seen in this mouse model (Guy et al., 2001).
Experimental Hypotheses and Implications
We propose that the AIS represents one “‘point of convergence’” of inhibitory synaptic
dysfunction, where independent molecular mechanisms cause alterations in AIS
properties. These alterations at the AIS in turn affect neuronal signal transmission in
various NDDs where epilepsy is a comorbid symptom. Specifically, we hypothesize that
an altered AIS morphology and/or composition can lead to the phenotypes seen in NDDs
including seizures. Previous studies of Gabra2-1 (Hines et al., 2018) and mice models of
RS (Boda et al., 2010; Spronsen & Hoogenraad, 2010) have focused on alterations in in
the structure and function of synapses, disregarding the examination of the AIS in greater
detail. Thus, it is unknown whether AIS plasticity occurs in the neurons of Gabra2-1 and
RS

mouse

models.

Understanding

neuropathological

changes

underlying

neurodevelopmental disorders will promote an understanding of general mechanisms
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underlying this heterogeneous class of disorders and contribute to the development of
better therapies.
In order to analyze the AIS, we performed immunofluorescent labeling of sodium
channels, an established marker for the AIS, in brain sections of mouse models of NDDs
with a high incidence of epilepsy and littermate controls for comparison. We quantified
the length, 2-D area, 2-D tortuosity, and relative sodium channel intensity of the AIS.
Other protocols including PCR genotyping from tail biopsies, and western blotting on brain
tissue were also performed. The animal models used were the established model for RS,
developed by knockout of one copy of the Mecp2 gene in female mice (Mecp2 +/-) and the
Gabra2-1 mice which have a substitution mutation in the ɑ2 subunit of GABA A receptors
and developmental epilepsy.
Hypothesis 1: The length and area of the AIS will decrease in Gabra2-1 and
Mecp2+/- mice when compared to wild-type mice.
Implications for Hypothesis 1: If the length and area of the AIS decreases
in Gabra2-1 and Mecp2+/- mice when compared to wild-type mice, then these data
would suggest activity‐dependent adaptations of the AIS.
Hypothesis 2: The tortuosity of the AIS will increase in Gabra2-1 and Mecp2+/- mice
when compared to wild-type mice.
Implications for Hypothesis 2: If the tortuosity of the AIS increases in
Gabra2-1 and Mecp2+/- mice when compared to wild-type mice, then these data
would suggest adaptation of AIS morphology to neuronal excitability.
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Hypothesis 3: The intensity of sodium channel staining will increase in Gabra2-1
and Mecp2+/- mice when compared to wild-type mice.
Implications for Hypothesis 3: If the intensity of Nav channel staining
increases in Gabra2-1 and Mecp2+/- mice when compared to wild-type, then these
data would suggest a possible increase in the number of Na v channels. Nav
channel expression will also be analyzed using Western Blots.
Conclusion
Numerous studies have shown GABAergic signaling dysfunction in a wide range of
NDDs. There is evidence linking AIS synapses to numerous neurological diseases. As
described in this literature review, the AIS and its synapses are known to have a
powerful role in coordinating neuronal activity patterns. Given that the AIS is enriched in
epilepsy-associated proteins and given the AIS’s role in AP firing, we predict that it will
similarly play an important role in AP firing dysfunction. Nevertheless, the AIS has not
been studied in detail and thus many important questions remain unanswered. For
example, we still have no direct evidence for a causal link between AIS morphology and
NDDs with a high incidence of epilepsy. Further experiments to interrogate AIS
morphological and compositional function in the context of NDDs with a high incidence
of epilepsy will be needed to advance our knowledge of the disease process. A greater
understanding of the direct role of AIS morphology in NDDs may open new avenues for
targeted therapies.
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CHAPTER 3: METHODOLOGY

Description/Justification of Subjects
More than 100 years of research using mice as models of human diseases have
provided us with great knowledge about how humans function. The mouse has a short
lifespan (one mouse year equals about 30 human years) and a fast reproduction rate
which allow us to study development in a timely and cost-effective manner. For all of the
experiments, female adult mice of each genotype were used unless otherwise specified;
wild-types as controls, Gabra2-1 Het., Gabra2-1 Homo., and Mecp2+/- from the Jackson
Laboratory (Stock Number 003890). All mice are housed in the Juanita Greer White Hall
animal facility at the University of Nevada, Las Vegas. Mice are kept on a 12-hour
light/dark cycle, with food pellets and water ad libitum.
General Experimental Procedures
Tail Biopsy for Genotyping (Polymerase Chain Reaction)
To determine each animal’s genotype, tail biopsy has been performed. Post weaning
animals were anaesthetized with 4% Isoflurane. Pups inhaled isoflurane until they lost
consciousness and failed to respond to tactile stimuli and to pinching of their paws. Hot
scissors direct from a bead sterilizer and previously cleaned with alcohol were used to
obtain the tail biopsies. Hot scissors ensure that the tails do not bleed following the
procedure. About 2-3 mm of the tip of the tail was removed. Following tail biopsy, animals
were monitored until they were fully awake and then returned to their homecage.
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Tissue Preparation- Tail Lysis
Each undigested tail sample (in the fridge if cut that day, in the freezer if cut earlier) was
digested in a solution containing 198µL Lysis buffer and 2µL Proteinase K. Samples were
placed on a heating block and incubated 5-6 hours to overnight. After incubation, samples
were placed in a digital dry bath at a temperature of up to 85℃ for 45 minutes to inactivate
proteinase. Samples were then spun for about 30 seconds to precipitate hairs/undigested
fragments. If Polymerase chain reaction (PCR) was not performed on the same day,
samples were stored in a freezer until PCR.
Polymerase Chain Reaction and Gel Electrophoresis
PCR technique was used to determine the genotype of samples. This technique amplifies
one or a few copies of a segment of DNA across several orders of magnitude in order to
generate thousands to millions of copies of that particular DNA sequence. We added 2uL
of each DNA sample (obtained from tail biopsies) into the PCR tubes while on ice. A
mixture of the following PCR reagents was added to each tube (in µL): 15.865 ddH20,
2.5 Reaction buffer, 1.375 MgCl2, 0.25 Triton-x, 0.75 Primer 1 a2-1F, 0.75 Primer 2 a21R, 1.25 DNTPs, and 0.26 Taq. Each tube was gently mixed and placed on Bio-Rad®
C1000 Touch Thermal Cycler.
During this procedure, reactants are exposed to cycles of repeated heating and
cooling that allow for different temperature-dependent reactions. We followed the
instructions that came with the master mix for the thermal cycling protocol: 2 minutes at
94°C (polymerase activation and DNA denaturation) then for 35 cycles, amplification
consisting of 30 seconds at 94°C (denaturation) and 30 seconds at 65°C (annealing) and
5 minutes at 72°C.
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The agarose gel was made by adjusting the amount of starting agarose to
1.5%g/100mL TAE (i.e. 1.5g agarose/100mL solution will give 1.5%). Ethidium Bromide
was used for detecting the DNA. The gels were loaded with 20µl of sample mixture from
25µl PCR reaction mixed with 6µl of 6X Sample Loading Buffer added to each well. Then,
the gels were ran at 90V until the dye line was approximately 75-80% of the way down
the gel and DNA fragments were visualized for genotyping.
Transcardial Perfusion
For histological studies, mice were deeply anesthetized with 4% Isoflurane until they no
longer responded to tactile stimuli and to pinching of the paws. They were then
transcardially perfused; blood was cleared with 0.1M Sorenson’s Phosphate buffer and
brain was perfused with PLP fixative (McLean & Nakane, 1974). Brains were then
removed and post fixed with PLP fixative. Later, brains were transferred to cryoprotectant
solution before freezing in 30% sucrose in 0.1M Sorenson’s Phosphate buffer. Brains
were then ready to be sectioned for histological examination.
Brains were coronally sectioned at a thickness of 40μm on a cryostat. Sections
were stored in a polyvinyl-pyrrolidone ethylene glycol cryoprotection solution at -20°C for
a maximum of 6 months.
Immunostaining
After transcardial perfusion, slices containing prefrontal cortex were washed in PBS-BupH
3 times for 10 minutes each. Then, sections were transferred to lysine sodium metaperiodate solution for 15 minutes. Sections were washed again in PBS-BupH 3 times for
10 minutes each. Sections were then transferred to blocking serum (10% normal goat
serum) for 2 hours at room temperature. To more readily identify the AIS, tissues were
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incubated overnight at 4°C in a humidity chamber in pan-sodium channel primary
antibody (rabbit) diluted in 2% normal goat serum. Primary antibody was removed by
washing the tissue in PBS-BupH 3 times for 10 minutes each. Alexa 488-conjugated goat
anti-rabbibt (1:1000 dilution) secondary antibody diluted in 2% normal goat serum was
applied for 2 hours at room temperature; this allows us to visualize primary antibody
through a microscope. Excess secondary antibody was removed by 3 consecutive 10 min
washes with PBS-BupH. Brain slices from WT, Gabra2-1, and Mecp2+/- mice were
prepared in parallel and mounted on coverslips. Fluorescence images of mPFC layer 3
were taken at 40x objective and acquired at identical exposure times. Stayin in the middle
of the mPFC (layer 3) allowed us to be more certain about our location in the brain.
Tissue Preparation for Western Blots
Mice were deeply anesthetized with isoflurane until they no longer responded to tactile
stimuli and to pinching of the paws. Mice were then decapitated, their brains were quickly
extracted, and both brain hemispheres were placed for 1 hour at 4°C in a lysis buffer
containing the following: 20mM Tris HCL at a pH of 7.4, 1% SDS, 50mM NaF, 1mM EDTA,
1mM Na2VO4, 250µg/ml AEBSF, 10µg/ml antipain, 10µg/ml leupeptin, and 1µg/ml
pepstatin. Following lysis, samples were centrifuged at maximum speed for 10 minutes
and supernatant was removed to be used for the western blotting procedure.
Western Blots
In order to examine protein expression at the frontal cortex, relative protein levels of pansodium channel 1:1000 was quantified by dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) Western blotting. We began by analyzing the protein
concentration which was determined using a full spectrum spectrophotometer. Loading
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amount for each sample was calculated in order to get equal concentrations of protein
among all samples. β-mercaptoethanol and 6x buffer mixture was added to protein
samples (68µl per 1ml of sample) and heated at 60°C for 15 minutes. Samples (20µg)
were separated on a 4-20% gradient gel and electro-transferred onto nitrocellulose
membranes. Following blocking with 5% milk and 1x PBS-Tween solution, membranes
were probed with actin and pan-sodium channel primary antibodies. Sections were then
incubated overnight in primary antibodies on a shaker in 4°C and subsequently washed
with 1x PBS-Tween. After the washes, membranes were probed with IRDye 800 CW Goat
anti rabbit and IRDye 680 RD Donkey anti mouse fluorescence-based secondary
antibodies at a concentration of 1:10,000. Finally, membranes were imaged using
Odyssey® Infrared Imaging System (LI-COR) and analyzed using Imagej (NIH) software.
All proteins of interest were normalized to b-actin.
Analysis
We began our morphological analysis of the AIS by looking at the initial segment of the
axons of previously Golgi Cox stained pyramidal neurons at the mPFC (Figure 1). To
make sure we were analyzing the initial section of the axon, we assured that the cell body
had a pyramidal shape and that the axon didn’t taper nor have spines (which dendrites
have). The analysis consisted of measuring 10µm from the neural soma along the axon
with a straight line (chord), then measuring the actual length of the AIS along this straight
line (arc). We also measured the width of the AIS by taking an average from 3 sections
within this length. Lastly, tortuosity was measured by taking the arc to chord ratio
(Arc:Chord). This experiment gave us a quick look at the initial segment of axons allowing
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us to determine whether changes are seen at the AIS of our Gabra2-1 mouse model when
compared to wild-type mice.
Quantifications of AIS length, 2-D area, 2-D tortuosity, and Corrected Total
Fluorescence (CTF) were obtained from microscopical images of immunostained panNaV channel antibody using ImageJ (NIH). Any image adjustments made were applied to
all images. For length and 2-D area quantification, we took a Z-projection of the images
in the Z-stack where the AIS was visible and measured each AIS by using the hand
tracing tool. For 2-D tortuosity index quantification, we took the ratio of the arc, the length
of the curve (A); to the chord, the distance between each AIS endpoint (C) [I=A/C]. A
straight AIS would have a tortuosity index of 1 meaning there is no tortuosity. To calculate
the CTF, each AIS was traced using the hand tracing tool and integrated density was
calculated. Various background areas were selected per image and the mean
fluorescence of background was calculated. A corrected total AIS fluorescence (CTF) of
the AIS was calculated using the following formula: CTAF = Integrated Density – (Area of
selected cell X Mean fluorescence of Bk). To analyze western blot data, we first
normalized the protein of interest band to the control band (b-actin).
Results

for

the

analysis

of

the

AIS

from

the

Golgi

Cox

and

immunohistolochemically stained images and western blots were statistically analyzed by
one-way between subjects ANOVA with group as the factor. Post-hoc comparisons of
treatment groups were performed following any significant ANOVA to determine group
significance.
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Figure 1

Schematic representation of the areas analyzed in the mouse brain and pyramidal neuron.
A Schematic drawing showing the mPFC. The brain was sliced in coronal sections represented by the red
dashed line. B Schematic drawing of a coronal section of the mouse brain highlighting the mPFC. The red
boxes represent the analyzed areas (layer 3 of the mPFC). C Schematic drawing of a pyramidal neuron
showing the AIS.
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CHAPTER 4: RESULTS

The Gabra2-1 Mutation Results in Structural Changes in the Axon Evidenced
by Golgi Cox Staining
Previous research on the Gabra2-1 mouse model demonstrated that there was a loss of
inhibitory synapses on the AIS of cortical pyramidal cells in both Het and Homo mice. Due
to the epileptic phenotype of the Gabra2-1 mice and the AIS’s function in AP generation,
we set out to examine the morphology of the axon in Gabra2-1 mice. We began with Golgi
Cox staining which allows examination of cell structure, including axons, dendrites and
dendritic spines. In Gabra2-1 mice, there were visually apparent changes in axonal
morphology in comparison to littermate wild-type control mice (Figure 2A). Our first
analysis consisted of measuring the mean width of the initial segment of the axon (arc)
within a 10µm chord projecting away from the soma which decreased for the Gabra2-1
mice when compared to wild-type mice (Figure 2B, C). While analyzing axonal width, we
became interested in another visually apparent morphological variation; axonal curvature.
We analyzed the 2-D tortuosity by measuring the arc length of the axon within the 10µm
chord length beginning where the axon leaves the cell body (Figure 2B, D). A tortuosity
(Arc:Chord) ratio of 1 means that the axon is straight, with a value greater than one
meaning there is some curvature. Strikingly, this analysis revealed a substantial increase
in the mean tortuosity (Arc:Chord) of Gabra2-1 Het and Homo pyramidal cell’s axonal
segments leaving the cell body when compared to wild-type mice. Comparison of the
results for the Gabra2-1 Het and Gabra2-1 Homo mice showed no significant difference.
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Figure 2

Morphological changes in Golgi Cox stained cortex pyramidal neurons of Gabra2-1 mice.
A Zoomed-in image of the mPFC pyramidal neuron’s axons of wild-type, Gabra2-1 Het, and Gabra2-1 Homo mice.
B Schematic representation of the axon of a pyramidal neuron depicting the 10µm chord and the arc used for
measurements. C Quantification of AIS width of first 10µm of axon in wild-type, Gabra2-1 Het, and Gabra2-1 Homo
mice (wild-type-0.806, SD= 0.177, SEM= 0.102, Gabra2-1 Het- 1.198, SD=0.138 SEM=0.0797, and Gabra2-1 Homo1.218, SD=0.0879, SEM=0.0508. Wild-type vs. Gabra2-1 Het t=3.447, P=0.027; wild-type vs Gabra2-1 Homo t=3.622,
P=0.033, Gabra2-1 Het vs. Gabra2-1 Homo P=0.867 -no significant difference. D Quantification of 2-D tortuosity
(arc:chord) in wild-type, Gabra2-1 Het, and Gabra2-1 Homo mice (wild-type-1.019, SD= 0.00587, Gabra2-1 Het-1.383,
SD= 0.0672, and Gabra2-1 Homo-1.484, SD=0.0757. Wild-type vs. Gabra2-1 Het t=7.610, P<0.001); wild-type vs
Gabra2-1 Homo t=7.610, P<0.001; Gabra2-1 Het vs. Gabra2-1 Homo P=0.079. N=3 mice for all the analyses.

Morphological and Proteinaceous Changes in the Axon Initial Segment of
Gabra2-1 Mice
The Golgi Cox analyses provided a promising lead regarding morphological changes in
the first 10µm of axon in cortical pyramidal cells of Gabra2-1 mice, yet Golgi Cox does
not allow for precise measurement of the AIS. To extend these analyses, we used
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immunohistochemical staining of AIS specific markers. The AIS requires a high density
of Nav channels for APs to be generated. Due to the importance of Na v channels in AP
generation and its enrichment at the AIS, we immunostained the AIS of pyramidal
neurons in the mPFC of our Gabra2-1 mouse model with a pan- Nav channel antibody
(Figure 3A). This allowed us to label only the AIS compartment for better analysis.
Substantial Decrease in Axon Initial Segment Length of Gabra2-1 Mice
Since immunostaining allowed us to view the AIS compartment from one end to the other,
we quickly noticed a visual difference in the AIS length of the Gabra2-1 mice when
compared to the AIS of the wild-type mice (Figure 3A). Measuring the length of the AIS
in tissue sections from layer 3 of the mPFC demonstrated a substantial decrease in
Gabra2-1 Het and Homo mice when compared to the wild-type mice (Figure 3B). The
mean AIS length for wild-type mice was significantly greater than both the Gabra2-1 Het
and Gabra2-1 homo mice, but there was no significant difference among the length of the
AIS of Gabra2-1 Het and Gabra2-1 homo mice.
No Significant Change Measured for the 2-Dimensional Area of Axon Initial
Segment in the Gabra2-1 Mice
Previous analysis of AIS revealed a decrease in length for the Gabra2-1 cortical pyramidal
cells compared to the wildtype mice. This change led us to wonder whether the area of
the AIS had also changed so, we set out to analyze the 2-dimensional area of the AIS by
using the Imagej program. Surprisingly, our analysis revealed that the 2-dimensional AIS
area of the Gabra2-1 mice did not change substantially (Figure 3C). Both, the Gabra2-1
Het and Homo mice had a 2-dimensional area that was close to that of the wild-type mice,
with no significant difference detected.
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Corrected Total Axon Initial Segment Fluorescence for the Gabra2-1 Mice
While analyzing the morphology of the AIS, we also noticed possible changes in the
intensity of fluorescence emitted by the stained sodium channel immunoreactivity (panNaV channel antibody). Thus, we performed an analysis of the Corrected Total
Fluorescence (CTF) on the AIS (Figure 3D). Results show a significant change for the
Gabra2-1 Het and Homo mice when compared to the wild-type mice. We also saw
significant difference in the CTF of the AIS when comparing the Gabra2-1 Homo to the
Gabra2-1 Het mice.
More Tortuous (Arc:Chord) Axon Initial Segment in the Gabra2-1 Mice
From observation, most of the AIS of wild-type mice were straight; only some AIS had
small arcs but also stayed within a relatively straight line. The AIS of Gabra2-1 mice had
visually more curvature to them (i.e. larger arcs). In order to analyze this observation, we
measured the straight line connecting the two ends of the AIS (Chord) and the length
along the AIS (Arc) (Figure 3E). Similar to the results we got from the tortuosity analysis
of axons from Golgi Cox stained neurons, AIS tortuosity (Arc:Chord) increased
significantly for the Gabra2-1 mice when compared to wild-type mice (Figure 3F). For
wild-type mice, the Arch and Chord lengths had a ratio near 1 while the tortuosity
(Arc:Chord) of AIS of Gabra2-1 mice were substantially greater than 1.
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Figure 3

Morphological Restructuring of axon initial segments measured from immunohistochemical analysis of
Gabra2-1 mice. A Staining for pan-sodium channel antibody to label the AIS of wild-type, Gabra2-1 Het, and Gabra21 Homo mice (scale= 20µm). B Quantification of AIS length in wild-type, Gabra2-1 Het, and Gabra2-1 Homo mice (wildtype-21.275µm, SD=0.412, SEM=0.238; Gabra2-1 Het-15.966µm, SD=0.875, SEM=0.505; Gabra2-1 Homo14.104µm, SD= 1.155, SEM=0.667). Wild-type vs. Gabra2-1 Het t= 7.478; P = <0.001, wild-type vs. Gabra2-1 Homo
t= 10.101; P = <0.001. C Quantification of AIS area of wild-type, Gabra2-1 Het, and Gabra2-1 Homo mice (wild-type19.723µm2, SD=0.909, SEM=0.525; Gabra2-1 Het-18.331µm2, SD=0.663, SEM=0.383; Gabra2-1 Homo-19.110µm2,
SD=0.758, SEM=0.438) Analysis of variation between groups P=0.174- not significant. D Quantification of the
Corrected Total AIS Fluorescence of wild-type, Gabra2-1 Het, and Gabra2-1 Homo mice (wild-type-440.538,
SD=90.989, SEM=52.533; Gabra2-1 Het -312.004, SD=17.866, SEM=10.315; Gabra2-1 Homo-204.704, SD=53.483,
SEM=30.879). Wild-type vs. Gabra2-1 Het t=2.547, P=0.044, wild-type vs. Gabra2-1 Homo t=4.674, P=0.007). E
Quantification of AIS Arc and Chord in wild-type (r2= 0.984), Gabra2-1 Het (r2= 0.866), and Gabra2-1 Homo (r2= 0.714)
mice. F Quantification of the tortuosity (Arc:Chord) at the AIS of wild-type, Gabra2-1 Het, and Gabra2-1 Homo mice
(wild-type-1.049, SD=0.0144, SEM=0.00829; Gabra2-1 Het-1.294, SD=0.0357, SEM=0.0202; Gabra2-1 Homo-1.359,
SD=0.0613, SEM=0.0354). Wild-type vs. Gabra2-1 Het t=7.183, P=<0.001, wild-type vs. Gabra2-1 Homo t=9.098,
P=<0.001. N=3 mice for all the analyses.

36

Developmental Expression of Pan-Sodium Channel Using Western Blots
Western blotting was performed to examine total expression of sodium channel proteins
to support the investigation of the AIS using immunohistochemistry. We performed
Western Blotting of cortical homogenates at multiple developmental time points (PND 0,
5, 10, and 20) comparing wild-type and Gabra2-1 Het mice (Figure 4A). In this analysis,
the relative intensity of the prominent pan-sodium channel band (250kDa) was normalized
to actin (45kDa) loading control. No significant differences were detected in the
expression of sodium channel proteins between wildtype and Gabra2-1 het mice at any
of the time points examined (PND 0, 5, 10, and 20) (Figure 4B).
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Figure 4

Western Blot time course of wild-type and
Gabra2-1 Het mice.
A Western Blots of wild-type vs. Gabra2-1 mice
at PND 0, PND 5, PND 10, and PND 20. B
Quantification of relative intensity of wild-type
vs. Gabra2-1 mice at PND 0, PND 5, PND 10,
and PND 20 (no significant results). N=3 mice
for all the analyses.
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In summary, our analysis of the AIS of Gabra2-1 mice showed that they were
shorter in length and more tortuous in comparison to the AIS of wild-type mice. To our
surprise, there was no change in the 2-D area of Gabra2-1 mice when compared to the
AIS of wild-type mice. We also saw a surprising decrease in the pan-sodium channel CTF
of the AIS of Gabra2-1 mice when compared to wild-types although the western blot
analysis showed no change in pan-sodium channel protein expression in brain cortex
homogenates. The Golgi Cox and immunostaining analyses of the Gabra2-1 mice
provided a promising lead regarding morphological changes in the axon of cortical
pyramidal cells in pathology. If results globalize to other NDDs, then this could provide
new avenues for further research. To further investigate the AIS in NDDs, we chose a
mouse model of RS (Mecp2+/-) due to the monogenetic nature of this disorder and the
fact that this model recapitulates the major human phenotypes seen in RS and other
NDDs.
Morphological and Proteinaceous Changes in the Axon Initial Segment of
Mecp2+/- Mice
To test whether our results for the Gabra2-1 mice would globalize to the Mecp2+/mouse model of RS with a high incidence of epilepsy, we immunostained the mPFC AIS
of pyramidal neurons with a pan-sodium channel antibody. Then we analyzed the
results following the same methods used for the analysis of the Gabra2-1 mouse
model for comparison. Results are summarized in the sections below.
Substantial Decrease in the Axon Initial Segment Length of Mecp2+/- Mice
We began our analysis of the AIS in tissue sections from the frontal cortex of Mecp2 +/mice by looking at its length. From observation, there was variation in the length of the
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AIS although, the majority looked smaller in comparison to the AIS of the wild-type
mice. As hypothesized, measuring the length of the AIS in tissue sections from layer 3
of the mPFC demonstrated a substantial decrease for the Mecp2+/- mice when
compared to wild-type mice (Figure 5B).
No Significant Change Measured for the 2-Dimensional Area of AIS in the
Mecp2+/- Mice
After analyzing the length of the AIS, we analyzed the 2-dimensional area of the AIS in
the Mecp2+/- mice. From observation, there was variation in the width of the AIS even
within the same Mecp2+/- mice in comparison to the wild-type mice which visually had a
more constant AIS width. The widths observed for the Mecp2+/- mice ranged from wider
AIS to AIS that looked like those form the wild-type mice. The results were unlike what
we had hypothesized; the 2-dimensional AIS area of the Mecp2+/- mice did not decrease
substantially when compared to the wild-type mice (Figure 5C).
Corrected Total Axon Initial Segment Fluorescence for the Mecp2+/- Mice
Interestingly, simple observation of the AIS of Mecp2+/- mice revealed brighter segments
in comparison to the AIS of wild-type mice. We thought this increase in brightness could
be for the whole images in general. To our surprise, the results from the analysis of the
Corrected Total Fluorescence (CTF) on the AIS the AIS of the Mecp2+/- mice show a
substantial increase in CTF when compared to the wild-type mice (Figure 5D).
More Tortuous (Arc:Chord) Axon Initial Segment in the Mecp2+/- Mice
Similar to the results we got from the tortuosity analysis of axons from Golgi Cox stained
neurons and the immunostaining analysis of AIS tortuosity (Arc:Chord) in Gabra2-1
mice, the Mecp2+/- mice also showed a more tortuous AIS. The tortuosity for wild-type

40

mice was close to 1 meaning the AISs were close to being straight. On the other hand,
the AIS of Gabra2-1 mice Mecp2+/- mice and were substantially greater than one
suggesting more curvature (Figure 5E, F).

Figure 5

Immunohistochemical analysis of axon initial segments in Mecp2+/- mice. A Staining for pan-sodium channel
antibody to label the AIS of wild-type and Mecp2+/- mice. B Quantification of AIS length in wild-type and Mecp2+/- mice
(wild-type-21.275µm, SD=0.412 (n=3), Mecep2+/--13.898µm, SD=0.798 (n=3) t = 14.235, P = <0.001. C Quantification
of the tortuosity (Arc:Chord) at the AIS of wild-type and Mecp2+/- mice (wild-types-1.049, SD=0.0144 (n=3), Mecp2+/-1.456, SD=0.059 (P = <0.001). D Quantification of AIS area of wild-type and Mecp2+/- mice (wild-type-19.723µm2,
SD=0.909 (n=3), Mecp2+/-- 17.456µm2, SD=2.231 (n=3). E Quantification of the Corrected Total AIS Fluorescence in
of wild-type and Mecp2+/- mice (wild-type-440.538, SD=90.989, Mecp2+/-- 697.351, SD=148.603 (no significant
difference). N=3 mice for all the analyses.
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In summary, our analysis of the AIS of Mecp2+/- mice showed that they were shorter
in length and more tortuous in comparison to the AIS of wild-type mice. To our surprise,
there was no change in the 2-D area Mecp2+/- mice when compared to the AIS of wildtype mice. We also saw an increase in the pan-sodium channel CTF of the AIS of Mecp2+/mice when compared to wild-types although, the western blot analysis showed no change
in pan-sodium channel protein expression in brain cortex homogenates. We then
combined the analyses with those conducted on Gabra2-1 mice for comparison.
Comparing and Contrasting Gabra2-1 and Mecp2+/The Gabra2-1 and Mecp2+/- mice are different models of NDDs that share phenotypes
also commonly seen in humans with these disorders. We wanted to check whether
these mice also share morphological changes at the AIS of cortical pyramidal cells.
Both, the Gabra2-1 and Mecp2+/- mice, had a decrease in AIS length when compared to
the wild-type AIS. When comparing the AIS of Gabra2-1 to the AIS of Mecp2+/- mice,
there was no substantial change in length (Figure 6B). When we measured the 2D-area
of the AIS, there was no significant change among all four genotypes (wild-type,
Gabra2-1 Het, Gabra2-1 Homo, and Mecp2+/-) (Figure 6C). For the CTF, we saw a
surprising decrease for the pan-sodium maker of the AIS of Gabra2-1 Het and Homo
mice and an increase for the Mecp2+/- mice. There was no significant difference
between the results for CTF of Gabra2-1 Het and Homo, but there were significant
differences when comparing the results of the Gabra2-1 Het mice to the Mecp2+/- mice
and the Gabra2-1 Homo mice to the Mecp2+/- mice (Figure 6D). We then measured the
tortuosity of the AIS and saw a significant difference between the AIS of Gabra2-1 Het
and Mecp2+/- mice which came out being more tortuous, but no difference was seen
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between the Gabra2-1 Homo and Mecp2+/- mice (Figure 6E, F). We were intrigued
about this striking finding in change in tortuosity at the AIS so we further investigated by
counting the number of AIS with arcs. Our criterion was to count a curvature as an arc if
it had an angle deviating from a straight line of 35° or more. We were unable to find a
criterion on the literature as to what degree of angle would affect the AIS’s function, but
we found that researchers use an angle of 35° or more to consider the 2-D tortuosity of
the artery to be clinically significant (Wessel et al., 2015). Our results show that wildtype mice had AIS with none to 1 arc with a few outliers which had 2 arcs. The arcs on
the AIS from the Gabra2-1 Het mice ranged from none to 3 with some outliers having 4
arcs. We got the same results for the range in number of arcs in the AIS of Mecp2+/mice. For the Gabra2-1 Homo mice, the AIS had number of arcs raging from none to 4
with a couple of outliers with 5 arcs (Figure 6G).
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Figure 6

Comparing and contrasting morphological restructuring of the axon initial segments measured from
immunohistochemical analysis of Gabra2-1 and Mecp2+/- mice. A Staining for pan-sodium channel antibody to
label the AIS of wild-type, Gabra2-1 Het, Gabra2-1 Homo and Mecp2+/- mice (scale= 20µm). B Quantification of AIS
length in wild-type, Gabra2-1 Het, Gabra2-1 Homo, and Mecp2+/- mice (wild-type-21.275µm, SD=0.412, SEM=0.238;
Gabra2-1 Het-15.966µm, SD=0.875, SEM=0.505; Gabra2-1 Homo-14.104µm, SD= 1.155, SEM=0.667; Mecep2+/-13.898µm, SD=0.798, SEM=0.460). Gabra2-1 Het vs. Gabra2-1 Homo P=0.090 -not significant; Gabra2-1 Het vs.
Mecp2+/- P=0.052 -not significant; Gabra2-1 Homo vs. Mecp2+/- P=0.775 -not significant. C Quantification of AIS area
of wild-type, Gabra2-1 Het, Gabra2-1 Homo, and Mecp2+/- mice (wild-type-19.723µm2, SD=0.909, SEM=0.525;
Gabra2-1 Het-18.331µm2, SD=0.663, SEM=0.383; Gabra2-1 Homo-19.110µm2, SD=0.758, SEM=0.438; Mecp2+/-17.456µm2, SD=2.231, SEM=1.288). Analysis of variation between groups P=0.245- not significant. D Quantification
of the Corrected Total AIS Fluorescence of wild-type, Gabra2-1 Het, Gabra2-1 Homo, and Mecp2+/- mice (wild-type440.538, SD=90.989, SEM=52.533; Gabra2-1 Het -312.004, SD=17.866, SEM=10.315; Gabra2-1 Homo-204.704,
SD=53.483, SEM=30.879; Mecp2+/-- 697.351, SD=148.603, SEM=85.796). Gabra2-1 Het vs. Gabra2-1 Homo P=0.078
-not significant; Gabra2-1 Het vs. Mecp2+/- P=0.011; Gabra2-1 Homo vs. Mecp2+/- P=0.006. E Schematic representation
of Arc and Chord used to measure 2-D tortuosity. F Quantification of the 2-D tortuosity (Arc:Chord) at the AIS of wildtype, Gabra2-1 Het, and Gabra2-1 Homo, and Mecp2+/- mice (wild-type-1.049, SD=0.0144, SEM=0.00829; Gabra2-1
Het-1.294, SD=0.0357, SEM=0.0202; Gabra2-1 Homo-1.359, SD=0.0613, SEM=0.0354, Mecp2+/--1.456, SD=0.059,
SEM=0.0340). Gabra2-1 Het vs. Gabra2-1 Homo P = 0.125 –not significant; Gabra2-1 Het vs. Mecp2+/- P=0.008;
Gabra2-1 Homo vs. Mecp2+/- P=0.067 -not significant. G Average number of arcs counted per AIS of wild-type, Gabra21 Het, and Gabra2-1 Homo, and Mecp2+/- mice (wild-type-0.448, SD=0.580, SEM=0.042; Gabra2-1 Het-1.350,
SD=0.893, SEM=0.067; Gabra2-1 Homo-1.890, SD=1.370 SEM=0.160; Mecp2+/--1.638, SD=1.071 SEM=0.071).
Gabra2-1 Het vs. Gabra2-1 Homo P<0.001; Gabra2-1 Het vs. Mecp2+/- P=0.005; Gabra2-1 Homo vs. Mecp2+/- P=0.050
-not significant. N=3 mice for all the analyses.
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CHAPTER 5: DISCUSSION

NDD subtypes are heterogeneous but they oftentimes share a common
symptomatology such as epilepsy. We noticed that some of these common symptoms
are indicative of disrupted brain signaling. Since neuronal firing is dependent on the
AIS, we set out to analyze this neuronal structure under pathology. Our analysis of
Golgi Cox stained pyramidal neurons of Gabra2-1 mice at the mPFC showed promising
results, but we had a limitation; because Golgi Cox stains the whole neuron, we were
not sure about where the AIS ended. To overcome this limitation, we measured only the
first section of the axon along a 10µm chord. For us to be able to analyze only the entire
AIS structure, we immunostained brain slices with a pan-sodium antibody. The AIS is
highly enriched in sodium channels which makes this protein a great candidate for
fluorescent staining of only the AIS. We imaged layer 3 of the mPFC and analysed the
AIS comparing Gabra2-1 Het and Gabra2-1 Homo mice to wild-type mice. The analysis
of the immunostained images of the AIS showed backing results to the analysis of the
Golgi stained neurons plus a few other striking results. We then wanted to check
whether our results for the Gabra2-1 mice would globalize to other NDDs and decided
to include to our analysis a mouse model for RS, the Mecp2+/-. Interestingly, the AIS of
the Mecp2+/- mice was also morphologically affected in similar ways to the Gabra2-1
mice.
Our analysis on the morphology of the Golgi Cox stained neurons (Gabra2-1
mice compared to wild-type mice) showed a slight increase in the width of the initial
axonal segment along a 10µm chord projecting away from the soma. Our subsequent
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analysis from the immunostains backed up this result with the analysis of the 2-D area
which had no significant change in the Gabra2-1 and Mecp2+/- mice when compared to
the wild-type mice. We originally hypothesized a decrease in area due to the possible
shortening of the AIS. Instead, the analysis revealed no substantial change in the area
of Gabra2-1 Het, Gabra2-1 Homo, and Mecp2+/- mice despite the reduction in AIS
length. This is indicative of an increase in the width of the AIS. As a rule of thumb, larger
diameter axons transmit APs faster than smaller diameter axons. This is because axons
with larger diameters offer less resistance to the ions flowing down the axon. Having
less resistance to the flow of ions allows for faster AP conduction. The mechanism
behind this change in AIS width is still unclear, but due to its implications, we speculate
that this change is one of the causes, instead of a consequence, of the epileptic
phenotype seen in a variety of NDDs. Our logic is that a neuron trying to compensate
for having too much excitation would have had a reduction instead of an increase in the
diameter of the AIS.
Our analysis of immunostained AIS also showed a substantial decrease in the
length of the AIS of the Gabra2-1 and the Mecp2+/- mice when compared to the wildtype mice. A change in AIS length affects the excitability and firing function of neurons
(Kuba et al., 2006; Kuba & Ohmori, 2009). There are two possible explanations for our
observed reduction in AIS length in the frontal cortex of Gabra2-1 and Mecp2+/- mice.
The first possibility is that the AIS may have adjusted its length to compensate after
experiencing too much excitation. This would imply that the seizures were causal in the
reduction in length of the AIS. This idea is backed-up by research demonstrating that
the AIS can undergo changes in size and location in response to alterations of a
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neuron’s ongoing electrical activity (Grubb & Burrone, 2010; Kaphazan et al., 2011;
Kuba et al., 2006, Kuba & Ohmori, 2009). An elegant study using computational models
of simplified and realistic somatodendritic morphologies to quantify its impact on AIS
plasticity showed that neurons with larger dendritic trees like pyramidal neurons (L5)
were most excitable when the AIS was longer (Gulledge & Bravo, 2016). AIS length has
also been shown to vary depending on the tuning frequency of neurons; higher tuning
frequency (more excitation) causes the AIS to shrink in length (Kuba et al., 2006). The
second possible explanation is that a shorter AIS may have been caused by an
unknown factor prior to the seizures. Future studies are needed to examine the AIS in
early development prior to the emergence of seizures in the Gabra2-1 and Mecp2+/mouse models.
Surprisingly, our analysis of sodium channel protein expression showed a slight
decrease in the CTF of pan-sodium channel antibody on the AIS of the Gabra2-1 Het
and Gabra2-1 Homo mice; the opposite of what we had hypothesized. Our rationale in
hypothesizing an increase in NaV channel expression stemmed from the idea that a
shorter AIS would have the NaV channels concentrated in a smaller area thus emitting
more fluorescence (CTF). An explanation to this could be from the fact that the AIS is
highly enriched in NaV channels which give it a lower threshold for APs. A reduction of
ion channels, specifically of the NaV channels, causing an increase in threshold for APs
could be a response to too much excitation. On the other hand, there was a substantial
increase in fluorescence observed for the Mecp2+/- mice. This difference in results was
surprising at first and hard to interpret, but we were able to get a better understanding
when taking into consideration the other morphological changes occurring at the AIS
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(change in width, length, and curvature). Keeping in mind that we only were analyzing
the AIS and were not able to measure CTF at other neuronal compartments, we
speculate that there may be a redistribution of NaV channels occurring at the pyramidal
neurons in the frontal cortex of Gabra2-1 and Mecp2+/- mice. This redistribution may
differ depending of the severity of the phenotypes seen and the subsequent change in
morphology, specifically in tortuosity.
During this research, we also performed western blots of brain cortex
homogenates to analyze cortex expression of various proteins. Specifically relevant to
this project, we analyzed total expression of sodium channel proteins. Western blots
revealed that the expression levels of NaV (relative intensity) in the AIS of wild-type and
Gabra2-1 Het did not differ significantly during the 4 periods of development analyzed
(PND 0, 5, 10, and 20). Relative NaV intensity in wild-type mice did not change from
PND 0 to PND 20 but seems to increase substantially by the time wild-type mice reach
adulthood. Changes in the CTF of pan-sodium channels stained at the AIS were seen in
adult Gabra2-1 mice, thus we will perform western blots on adult mice for completion of
this time-course experiment. Ideally, western blots would have also been performed on
Gabra2-1 Homo mice but tissue collection has been more challenging due to early
mortality of these pups (Hines et al., 2018). Based on our results from length and CTAF
analysis, we may see a slight decrease in the relative intensity reflecting a decrease in
NaV channels at the AIS of Gabra2-1 mice. If this decrease occurs, it may be due to the
AIS trying to compensate for so much excitation by reducing the amount of Na V
available for the generation of APs. This hypothesis is linked to the findings that show
AIS plasticity due to changes in neuronal excitation (Kuba et al., 2006; Kuba & Ohmori,
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2009). Western blot analysis may also show no significant change in the cortex and this
may support our speculation of a redistribution of the sodium channels instead of a
change in quantity.
Our

results

from

the

analysis

of

Golgi

Cox

stained

neurons

and

immunohistochemical analysis of the AIS also showed a substantial increase in the 2-D
tortuosity (Arc:Chord) of the AIS of Gabra2-1 and the Mecp2+/- mice. Along with the
increase in 2-D tortuosity, we saw an increase in the number of arcs with an angle of 35
degrees or greater when comparing the Gabra2-1 and Mecp2+/- to wild-type mice. The
AIS of Gabra2-1 Homo mice had the greatest average number of arcs while the AIS of
Mecp2+/- had the greatest tortuosity. The reason for these results is still unknown. The
increase in 2-D tortuosity and number of arcs may suggest an activity‐dependent
adaptation of AIS morphology to neuronal excitability possibly through a change in the
cytoskeletal organization of the AIS. The AIS can be divided into three main layers or
regions: the plasma membrane (outermost surface), submembrane cytoskeleton
corresponding to the plasma membrane undercoat (middle layer), and inner AIS shaft
(cytoplasmic region) (Jones & Svitkina, 2016). The plasma membrane of the AIS is
enriched with specialized transmembrane proteins, including voltage-gated ion channels
important for the AIS electrical properties. The central component of the AIS
submembrane cytoskeleton is ankyrin G (AnkG) (Kordeli et al., 1995) which organizes
the AIS scaffold by anchoring AIS-specific membrane proteins such as the Nav channels
(Hedstrom et al., 2008). The submembrane complex in axons was also shown to be
periodically organized by actin rings which results in a periodic organization of Nav and
other channels (Xu et al., 2013). The structure of the AIS depends on this high
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organization and linkage between proteins; any disruption to this internal organization
may change the shape of the AIS, such as adding kinks and turns, which may interrupt
the flow of ions. We speculate that this change in tortuosity may be a consequence of the
epileptic phenotype seen in a variety of NDDs. The mechanism is still unclear, but our
logic is that a neuron may change its shape in order to prevent further excitation by
reducing the flow of ions. A disruption to this AIS internal organization could thus affect
action potential generation, although there is still no research backing this idea.
The AIS is an extremely important neuronal compartment for the generation of Aps
which is in turn dependent on AIS morphology and composition; and these parameters
adapt to developmental and physiological conditions (Grubb & Burrone, 2010; Kuba et
al., 2010). Although it has been widely accepted that the morphology of the AIS can
change rapidly in response to neuronal activity, until recently, long-term changes
occurring at the AIS during neuropathology remained entirely unknown.
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Figure 7

Schematic representation of axon initial segments of cortex pyramidal neuron depicting morphological
differences measured at layer 3 of the Mpfc according to genotype. Morphology of the AIS of wild-type, Gabra2-1
Het, Gabra2-1 Homo, and Mecp2+/- mice is shown based on our findings. Change in color of the AIS represents pansodium channel expression (CTF) measured.

Recent research has mostly shown changes in AIS morphology and/or protein
composition as a result of changes in neuronal input activity (please refer to the section
titled “AIS Plasticity”). There is a limited amount of research that has looked at how the
morphology and composition of the AIS is affected specifically in NDDs. One example,
mentioned in our literature review section, is the study demonstrating resting membrane
potential, threshold potential, and action potential amplitude changes in pyramidal
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neurons from a mouse model of AS (Kaphazan et al., 2011). These altered properties in
the AS mice were correlated with increases in the expression of NaV1.6 and ankyrin-G,
and the length of the AIS (Kaphazan et al., 2011). These results are strikingly similar to
our results and support our speculation of a redistribution of proteins at the AIS.
Specifically, both studies saw a change in the length of the AIS. We saw a decrease
instead of an increase in AIS length, but something important to note is that this mouse
model of AS displayed no epileptic phenotype (a symptom oftentimes seen in NDDs).
This is important because it tells us that the AIS shrinks its length when there is too much
excitation as we see in the epileptic phenotype. We both also saw changes in protein
expression at the AIS. Specifically, for our pan-sodium channel antibody expression at
the AIS, we saw a decrease for the Gabra2-1 mice and an increase for the Mecp2+/- mice.
With our research results, we have shown that there are morphological changes
at the AIS of Gabra2-1 and Mecp2+/- mice, two genetically distinct models of NDD with a
high incidence of epilepsy. Combining our results with previous research findings, the AIS
stands out as a possible point of convergence whose structural properties may be altered
by a heterogeneous range of mutations. As previously noted, the similar symptoms seen
among different NDDs may be indicative of a limit to the way our brains respond to
pathologies. Specifically, since the morphology and composition of the AIS seems to be
affected in NDDs, we speculate that this ultimately contributes to phenotypes such as
seizures.
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To the best of our knowledge, these findings are the first evidence of morphological
changes at the AIS in these models, providing a novel avenue for further
neuropathological investigation, and for the investigation of new therapeutic strategies.
Although, there are still many unanswered questions pertaining the role of the AIS in
typical and atypical neurodevelopment. For example, the underlying mechanisms for the
common symptoms seen in NDDs have yet to be studied. Specifically, we are still trying
to understand how the AIS is affected under these neuropathologies and whether AIS
abnormalities may contribute to the symptoms of NDDs. More research needs to be done
in order to pinpoint similarities among the way our brain reacts to the different mutations
causing NDDs.
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CHAPTER 6: FUTURE DIRECTIONS

The studies mentioned above have demonstrated that neuronal excitability can be
modulated through changes at the AIS. It remains to be established whether the
morphological changes at the AIS play a causal role in disease pathogenesis or result as
a consequence of it. We have started a developmental time-course analysis of AIS’s
morphology in order to investigate whether changes seen at the AIS occur before or after
the seizures. AIS’s morphology at PND 0, 5, 10, and 20 along with EEG recordings will
help explain whether the change in length occurs before or after the mice start
experiencing seizures. Previous observations on Gabra2-1 Het and Homo mice at our lab
have shown the seizure phenotype emerging around PND 10 and pups dying prior to
weaning with the peak of mortality falling on PND 20. Given the early mortality and the
occurrence of spontaneous seizures in pups, we hypothesize that the onset of seizures
occurs postnatally at around PND 10, and that this causes the changes seen in AIS
morphology of Gabra2–1 when compared to wild-types. If indeed, having a wider
diameter causes the neuron to have faster conduction of APs, then we would see that
this change occurs earlier in development and most likely before PND 10. On the other
hand, changes that we suggest are compensations for too much excitation, such as a
decrease in length, relocation of NaV channels, and tortuosity of the AIS should be seen
later in development for the surviving mice.
We will also examine AIS cytoskeletal organization in order to figure out if there
are changes in the structural organization. In order to do this, we will perform expansion
microscopy which will allow for higher-resolution images by physically enlarging the AIS
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itself. The central component of the AIS submembrane cytoskeleton is ankyrin G (AnkG)
(Kordeli et al., 1995) which organizes the AIS scaffold by anchoring AIS-specific
membrane proteins such as the Nav channels (Hedstrom et al., 2008). The submembrane
complex in axons was shown to be periodically organized by actin rings resulting in a
periodic organization of Nav and other channels as well (Xu et al., 2013).
Our lab is also currently investigating structure-function relationships at the AIS
using live imaging of calcium and voltage at the AIS. Since the AIS is fundamental to the
ability of neurons to fire action potentials, it is important to determine whether changes in
AIS morphology and/or composition relate to changes in neuronal excitability. We
hypothesize that altering AIS morphology and composition should be an effective
mechanism for regulating neuronal activity, and may present a novel therapeutic strategy
in treating NDDs.
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CHAPTER 7: CONCLUSION

Although NDDs are heterogeneous, they share a common behavioral symptomatology
which can include difficulties with language and speech, motor skills, behavior, memory,
learning, and/or other neurological functions. Besides the core symptoms, NDDs are
often comorbid with epilepsy. Based on these observations and previous research
findings, we proposed that NDDs might share a ‘point of convergence’ at the AIS
reflecting common pathologies and mechanisms. This could be in terms of non-related
pathogenic mechanisms that cause similar effects on neuronal function ultimately
leading to phenotypes such as epilepsy. We focused our study on the AIS of mouse
models of NDDs with a high incidence of epilepsy due to the AIS’s role in regulating
neuronal firing patterns. Our results show alterations in the morphology and protein
composition at the AIS. Therefore, the AIS may be a point of convergence whose
structural properties may be altered by a heterogeneous range of mutations.
Finding converging pathogenic mechanisms could help us refine and improve
available treatments for NDDs and epilepsy syndromes. The AIS might be a good target
for the treatment of NDDs with a high incidence of epilepsy and even for the epilepsies
themselves.
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Title: Research Assistant
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Faculty Advisor: Rochelle Hines Ph.D and Dustin Hines Ph.D
Responsibilities:
-Glial cells immunostaining and analysis
-Assisting in Transcardial Perfusions abd collecting tissue samples.
--Assisting in operation of biochemical assays including
immunohistochemistry, Western blot, polymerase chain reaction, and
protein concentration assay.
-Assisting in handling research animals
-Animal husbandry including breeding, weaning, genotyping, and colony
tracking.
- Basics of Electroencephalography, Sleep Analysis Software (SlipSign),
T-test, ANOVA, and Western Blot in preparation for new research on
GABA receptors. Practicing effective presentation skills.
University of Nevada, Las Vegas Reasoning and Memory Laboratory (RAM
lab)
Spring 2015
Faculty Advisor: Dr. David Copeland
Title: Research Assistant
Responsibilities:
-Assisting in examining memory processes and representations with a
focus on mental models.
-Studying different types of memory such as individual differences in
working memory.
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-Exploring mental models that people construct in long-term memory when
reading short stories.
-Creating the short stories used in these studies.
-Analysing results
University of Nevada, Las Vegas Dr. Rodriguez’s laboratory
2014
Faculty Advisor: Dr. Javier A. Rodriguez Ph.D working with Dr. Tereza Jezkova
Ph.D
Responsibilities:
·

-Performing molecular biology techniques such as polymerase chain
reaction
-Using genetic and environmental data to reconstruct endangered species’
responses to climatic changes. This research focused on the
phylogeography of species from Puerto Rico eastern Caribbean Sea, and
western North America.
(systematics, population, and evolutionary ecology of snakes and frogs)

Campus Activities and Leadership
Presenting Member of Neuroscience Journal Club; 2015–present
PSY 303 - Physiology of Psychology tutor; Fall 2016-Fall 2018
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Professional References
Dr. Rochelle Hines, Ph.D.
(Supervisor)
Assistant Professor, Department of Psychology, University of Nevada, Las Vegas
Office: CBC-B 333
Mail Code: 5030
Phone: 702-895-0187
Email: rochelle.hines@unlv.edu

Dr. Dustin Hines, Ph.D.
(Supervisor)
Assistant Professor, Department of Psychology, University of Nevada, Las Vegas
Office: CBC-B 335
Mail Code: 5030
Phone: 702-895-2208
Email: dustin.hines@unlv.ed
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